骨髓增生异常综合征中的核糖体生物发生缺陷。
Defective ribosome biogenesis in myelodysplastic syndromes.
出版信息
Haematologica. 2009 Oct;94(10):1336-8. doi: 10.3324/haematol.2009.012021.
Abstract
Myelodysplastic syndromes are poorly understood at the biological level. In this perspective article, Drs. Galili, Qasim and Raza examine the role of defective ribosome biogenesis in the pathophysiology of myelodysplastic syndromes. See related paper on page 1453.
摘要
骨髓增生异常综合征在生物学层面上的了解还很有限。在这篇观点文章中，Galili 博士、Qasim 博士和 Raza 博士探讨了核糖体生物发生缺陷在骨髓增生异常综合征病理生理学中的作用。见第 1453 页相关论文。
相似文献
1
Defective ribosome biogenesis in myelodysplastic syndromes.骨髓增生异常综合征中的核糖体生物发生缺陷。
Haematologica. 2009 Oct;94(10):1336-8. doi: 10.3324/haematol.2009.012021.
2
The biology and treatment of myelodysplastic syndromes.骨髓增生异常综合征的生物学特性与治疗
Rinsho Ketsueki. 2013 Oct;54(10):1730-6.
3
Acquired ribosomopathies in leukemia and solid tumors.白血病和实体瘤中的获得性核糖体病。
Hematology Am Soc Hematol Educ Program. 2017 Dec 8;2017(1):716-719. doi: 10.1182/asheducation-2017.1.716.
4
Myelodysplastic syndrome with isolated 5q deletion (5q- syndrome). A clonal stem cell disorder characterized by defective ribosome biogenesis.伴有孤立性5q缺失的骨髓增生异常综合征（5q-综合征）。一种以核糖体生物合成缺陷为特征的克隆性干细胞疾病。
Haematologica. 2008 Jul;93(7):967-72. doi: 10.3324/haematol.13377.
5
[Myelodysplastic syndromes--clinical and biological features].
Gan To Kagaku Ryoho. 1994 Feb;21(2):135-40.
6
Ribosomopathies: human disorders of ribosome dysfunction.核糖体病：核糖体功能障碍的人类疾病。
Blood. 2010 Apr 22;115(16):3196-205. doi: 10.1182/blood-2009-10-178129. Epub 2010 Mar 1.
7
Haploinsufficiency of multiple del(5q) genes induce B cell abnormalities in mice.多个5号染色体长臂缺失（del(5q)）基因的单倍剂量不足在小鼠中诱发B细胞异常。
Leuk Res. 2020 Sep;96:106428. doi: 10.1016/j.leukres.2020.106428. Epub 2020 Jul 23.
8
RPL27A is a target of miR-595 and may contribute to the myelodysplastic phenotype through ribosomal dysgenesis.RPL27A是miR-595的一个靶点，可能通过核糖体发育异常导致骨髓增生异常表型。
Oncotarget. 2016 Jul 26;7(30):47875-47890. doi: 10.18632/oncotarget.10293.
9
Chromosomal abnormalities in marrow stromal cells from myelodysplastic syndromes (MDS).
Blood. 2006 Dec 1;108(12):3948; author reply 3948-9. doi: 10.1182/blood-2006-08-040618.
10
Myelodysplastic syndromes: the complexity of stem-cell diseases.骨髓增生异常综合征：干细胞疾病的复杂性
Nat Rev Cancer. 2007 Feb;7(2):118-29. doi: 10.1038/nrc2047.
引用本文的文献
1
Fanca deficiency is associated with alterations in osteoclastogenesis that are rescued by TNFα.范可尼贫血蛋白C（Fanca）缺乏与破骨细胞生成的改变有关，而肿瘤坏死因子α（TNFα）可挽救这种改变。
Cell Biosci. 2023 Jun 24;13(1):115. doi: 10.1186/s13578-023-01067-7.
2
Concurrent Zrsr2 mutation and Tet2 loss promote myelodysplastic neoplasm in mice.Zrsr2 突变与 Tet2 缺失协同促进小鼠骨髓增生异常性肿瘤。
Leukemia. 2022 Oct;36(10):2509-2518. doi: 10.1038/s41375-022-01674-2. Epub 2022 Aug 27.
3
Deficiency and haploinsufficiency of histone macroH2A1.1 in mice recapitulate hematopoietic defects of human myelodysplastic syndrome.组蛋白巨 H2A1.1 的缺乏和杂合性不足可在小鼠中重现人类骨髓增生异常综合征的造血缺陷。
Clin Epigenetics. 2019 Aug 22;11(1):121. doi: 10.1186/s13148-019-0724-z.
4
Extracellular vesicles impose quiescence on residual hematopoietic stem cells in the leukemic niche.细胞外囊泡使白血病龛位中的残留造血干细胞处于静止状态。
EMBO Rep. 2019 Jul;20(7):e47546. doi: 10.15252/embr.201847546. Epub 2019 Jun 17.
本文引用的文献
1
Low RPS14 expression is common in myelodysplastic syndromes without 5q- aberration and defines a subgroup of patients with prolonged survival.低 RPS14 表达在不伴有 5q- 异常的骨髓增生异常综合征中很常见，并定义了具有延长生存的患者亚组。
Haematologica. 2009 Oct;94(10):1453-5. doi: 10.3324/haematol.2009.008508.
2
Blinded by the Light: The Growing Complexity of p53.被光蒙蔽：p53日益复杂的情况
Cell. 2009 May 1;137(3):413-31. doi: 10.1016/j.cell.2009.04.037.
3
Ribosomal mutations cause p53-mediated dark skin and pleiotropic effects.核糖体突变导致p53介导的黑皮肤和多效性效应。
Nat Genet. 2008 Aug;40(8):963-70. doi: 10.1038/ng.188. Epub 2008 Jul 20.
4
Haploinsufficiency of RPS14 in 5q- syndrome is associated with deregulation of ribosomal- and translation-related genes.5q-综合征中RPS14单倍剂量不足与核糖体及翻译相关基因的调控异常有关。
Br J Haematol. 2008 Jul;142(1):57-64. doi: 10.1111/j.1365-2141.2008.07178.x. Epub 2008 May 8.
5
An erythroid differentiation signature predicts response to lenalidomide in myelodysplastic syndrome.红系分化特征可预测骨髓增生异常综合征对来那度胺的反应。
PLoS Med. 2008 Feb;5(2):e35. doi: 10.1371/journal.pmed.0050035.
6
Identification of RPS14 as a 5q- syndrome gene by RNA interference screen.通过RNA干扰筛选鉴定RPS14为5q-综合征基因。
Nature. 2008 Jan 17;451(7176):335-9. doi: 10.1038/nature06494.
7
Gene expression profiling of CD34+ cells in patients with the 5q- syndrome.5q-综合征患者CD34+细胞的基因表达谱分析。
Br J Haematol. 2007 Nov;139(4):578-89. doi: 10.1111/j.1365-2141.2007.06833.x. Epub 2007 Oct 3.
8
The Shwachman-Diamond SBDS protein localizes to the nucleolus.施瓦赫曼-戴蒙德综合征（Shwachman-Diamond syndrome）的SBDS蛋白定位于核仁。
Blood. 2005 Aug 15;106(4):1253-8. doi: 10.1182/blood-2005-02-0807. Epub 2005 Apr 28.
9
Evidence for a role of TNF-related apoptosis-inducing ligand (TRAIL) in the anemia of myelodysplastic syndromes.肿瘤坏死因子相关凋亡诱导配体（TRAIL）在骨髓增生异常综合征贫血中作用的证据。
Am J Pathol. 2005 Feb;166(2):557-63. doi: 10.1016/S0002-9440(10)62277-8.
10
Mutations in SBDS are associated with Shwachman-Diamond syndrome.SBDS基因的突变与施瓦赫曼-戴蒙德综合征相关。
Nat Genet. 2003 Jan;33(1):97-101. doi: 10.1038/ng1062. Epub 2002 Dec 23.
Zotero 插件